Genetics for everyone – The Boston Globe

Illustration by cristina span/for the boston globe

The Greeks asked their oracles to predict future fortunes and future losses. The Romans studied the entrails of sacrificed animals for similar reasons. In modern-day medicine, though, soothsayers come in the form of genetic tests.

Ever since the human genome was sequenced almost 15 years ago, tens of thousands of genetic tests have flooded the marketplace. By analyzing someones DNA, often through a blood sample or cheek swab, these tests promise to foretell whether a patient is prone to certain cancers, blessed with the potential to become a star soccer player, or at an elevated risk of having an opioid addiction.

Advertisement

These types of genetic tests are finding an eager audience. The North American genetic testing market, already the largest in the world, was worth $11.9 billion in 2016, by one estimate, and is expected to grow at more than 15 percent a year for the foreseeable future. Companies such as LabCorp, which offer genetic tests via doctor recommendations, and the healthcare giant Roche have moved aggressively into the field. The company 23andMe, a household name because of its ancestry tests, sells health-related tests directly to consumers.

But for a source of medical information to be legally sold in the United States, just how accurate does it need to be?

Like a prediction from a crystal ball, genetic test results are sometimes wrong. Some tests that predict the likelihood a young pregnant woman will have a child with a genetic condition such as Down syndrome may only be correct only 60 percent of the time. Most genetic tests, and many other lab tests, go unvetted by the Food and Drug Administration. That means these tests may not undergo any independent review to make sure they accurately pick up the disease or genetic conditions they claim to be seeking.

Using the worlds first portable DNA lab to sequence beer is a cool thing to do.

The FDA has been wrestling for years with whether and how to do more. During the Obama administration, the agency proposed a new set of draft limits on a whole class of tests, and then put them on hold immediately after Donald Trumps election. This spring, the FDA gave 23andMe permission to market genetic screenings for susceptibility to Alzheimers, Parkinsons, and other conditions. It was the first time the agency blessed direct-to-consumer tests for genetic health risks.

While the debate over genetic testing often follows a pattern familiar from countless other industries business groups want less regulation, and consumer advocates favor more it also raises more cosmic questions: Is a medical test just a piece of information? Or is it something more, if its result leads to dramatic or irreversible action such as chemotherapy or an abortion? And if a data point is factually suspect, or ripe for misinterpretation, when and how should it be offered to consumers?

Advertisement

Especially if regulators stand aside, Americans may soon be swimming in even more tests that vary greatly in their reliability. Yet for some people contemplating a current ailment or their future well-being, getting an answer even an unreliable one may be better than no answer at all.

Especially for people expecting a baby, genetic tests can be hard to resist. I think we all are wanting to know our child doesnt have something... we want them to be healthy, said Mischa Livingstone, a filmmaker and professor who lives in California. Without asking for it, his pregnant wife, Jessica, was given a genetic test that predicted a 99 percent chance their child would have Turner syndrome, a genetic condition that can lead to short stature, heart defects, and other symptoms. But genetic tests for Turner are more often wrong than right a fact the couple didnt know at the time.

They were devastated, and immediately went for more invasive testing, which showed the fetus was fine. But their sense of dread didnt lift until their daughter, now 2 1/2, was born perfectly healthy.

Despite the heartache a faulty genetic test result caused, Livingstone says hed consider asking for one again. I think it feeds into that need for certainty, he said.

Both individuals and society as a whole are intolerant of the unknown, medical sociologists say.

Long before genetic screenings, there was a critical relationship between lab tests and medical treatment. Doctors often wont prescribe drugs or treatment without a positive test result. Insurance payments are rarely processed without diagnostic codes. The rise of genetic testing wont change, and may even amplify, that dynamic.

While some diagnoses may still carry social stigma think schizophrenia, for example they more often may confer legitimacy. Having a gene for alcoholism, for example, can make people view the problem as biological, as opposed to a character flaw. For patients, genetic tests promote a therapeutic optimism a hope that they can be treated and cured for an immediate problem or a future one, according to Michael Bury, professor emeritus at Royal Holloway, University of London, who studies society and illness.

A test alone can feel like a step forward. Undergoing a screening, said Natalie Armstrong, professor of healthcare improvement research at the University of Leicester, can make people feel that at least they are doing something proactive.

Interestingly, one study indicated that certain direct-to-consumer genetic tests dont affect users behavior or anxiety levels, bolstering the argument that people may use the information as data points, not a surefire prediction of their own fate.

Many bioethicists are unpersuaded. On an individual basis, it is tempting to discount the pitfalls of a little extra information, says Beth Peshkin, an oncology professor and genetic counselor at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. But on a population level the implications of inaccurate results can be costly and, sometimes, deadly.

One of the most cited examples of this harm is from a 2008 genetic test for ovarian cancer that misdiagnosed women, some of whom had their ovaries removed unnecessarily before the test was pulled from the market. Because test makers do not have to report when a test turns out to be wrong in fact many people may never know when a test result is a false positive or negative FDA officials have said it has been almost impossible to assess the overall harm from all unregulated tests.

Cost is another concern that may arise from the overuse of genetic tests that proliferate without meaningful oversight. Tests often beget more tests that cost an ever-escalating amount of money. Enough testing, will invariably pick up something abnormal in a patient, even though it may not harm them, some experts believe.

In some ways its easy for us to try and find something definitive and act on that even though it has nothing to do with what is wrong with the patient, said H. Gilbert Welch, a cancer research at Dartmouth College who has written extensively on the dangers of overtesting. Genetics is an amazing tool... but to what extent does that data predict something that you care about? Is it useful knowledge?

Get This Week in Opinion in your inbox:

Globe Opinion's must-reads, delivered to you every Sunday.

The American Clinical Laboratory Association, the key trade group for genetic test makers, and other advocates of lighter regulation argue that bad tests are rare, and that its more important for the free market to allow innovation. With more tests in place to identify disease, cures come next, they say.

So far, the public has shown little concern about the fallout of genetic testing. While a 2016 poll showed only 6 percent of American adults have undergone genetic testing, 56 percent of them said they would want to if it could predict cancer or a disease like Alzheimers. Most Americans, the poll found, believe genetic tests for predicting disease are mostly accurate and reliable.

Safety advocates best chance to tighten regulation may have already passed. The world of genetic testing becomes more free-wheeling and consumer-driven all the time. By one industry estimate, 10 new genetic testing products enter the market each day. Despite considerable skepticism from medical experts, new apps purport to use data from gene sequencing to develop personalized diet plans and fitness routines.

The FDAs now-shelved rules would have classified genetic and other tests according to how much harm they could cause if their result was wrong. For example, a new genetic test for colon cancer, which requires intrusive and costly treatment, likely would have been subject to full FDA review; the maker of a test that predicts mere baldness might only have had to register it with the agency and report any known problems with it. Under the Trump administration, the agency appears less likely to draw such distinctions or impose new restrictions at all.

People want answers soon, and their inclination is to believe what appears to be solid, unassailable medicine, said Robert Klitzman, a Columbia University bioethicist. Individuals will need to evaluate these tests carefully. The notion of being able to tell your fortune has great lure. But its a little bit of hubris. We still dont know so much.

Genetic testing, still in its infancy, promises a measure of clarity about the future of our bodies. But as genetic science rapidly evolves, that modern-day crystal ball raises vexing new questions and creates its own kind of uncertainty.

View post:
Genetics for everyone - The Boston Globe

Drilling Down Into Myriad Genetics, Inc. (MYGN) – StockNewsJournal

Myriad Genetics, Inc. (MYGN) is an interesting player in the Services space, with a focus on Research Services. The stock has been active on the tape, currently trading at $29.52, up from yesterdays close by 0.92%. Given the stocks recent action, it seemed like a good time to take a closer look at the companys recent data.

Fundamental Analysis

This company has been competing with others in the Services space and offers its own combination of interesting factors Myriad Genetics, Inc. (MYGN) currently trades with a market capitalization of $2.03 Billion. That value represents a market adjusting for revenues that have been growing by 7.56 % on a quarterly year/year basis as of the companys last quarterly report.

The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For MYGN, the company currently has $102.4 Million of cash on the books. You can get a sense of how sustainable that is by a levered free cash flow of $100.1 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.21 on a per share basis this quarter. Perhaps, that suggests something about why 96.67% of the outstanding share supply is held by institutional investors.

Technical Analysis

Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stocks movement on the chart, Myriad Genetics, Inc. recorded a 52-week high of $29.52. It is now trading 0% off that level. The stock is trading $25.76 its 50-day moving average by -3.76%. The stock carved out a 52-week low down at $15.15.

In recent action, Myriad Genetics, Inc. (MYGN) has made a move of +25.83% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is outperforming the S&P 500 by 27.56, and its gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 31.15% with $67.78 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of MYGN.

Read the original post:
Drilling Down Into Myriad Genetics, Inc. (MYGN) - StockNewsJournal

Studying Human Behavior in Dog Agility – The Bark (blog)

Investigating sex differences in the role of stress and hormones on affiliative behavior by people was the goal of a recent study. For anyone interested in the influence of hormones on behavior, the results are exciting, but its the dog angle thats most noteworthy to me.

The study measured peoples affiliative behavior towards their dogs after victory or defeat in an agility competition. (A qualifying score of 85 or better was considered a victory. Scores below 85 were classified as defeats.) Its gratifying that the researchers recognized the truly competitive nature of canine agility and its usefulness for studying reactions to victory and defeat. The main finding was that men and women exhibit different patterns of affiliative behavior based on whether they experienced success or failure, but they did not show different amounts of affiliative behavior overall.

One specific finding was that after defeat, women were more affiliative towards their dogs, but that men showed the reverse patternmore affiliative behavior after victory. Additionally, the higher their cortisol levels (associated with defeat), the more affiliative behavior the women showed, but men responded to higher cortisol levels with lower levels of affiliative behavior. Their conclusion is that affiliative behavior is a sign of shared celebration for men, but of shared consolation for women. (Its not clear how this impacts peoples relationships with their dogs as that was beyond the scope of this study, but I would LOVE to see further research that explores that question.)

Since the paper is written mainly for scientists concerned with the role of social stressors and hormones on affiliative behavior rather than for people interested in dogs, they had to explain what agility is and make the case that it is truly competitive. They wrote, As a rule, contestants take these competitions very seriously,an obvious understatement.

With their choice to study human affiliative behavior in the context of agility, the authors demonstrated the ever- increasing recognition of the importance of dogs in peoples lives.

Excerpt from:
Studying Human Behavior in Dog Agility - The Bark (blog)

Magnetothermal Genetics: A Fourth Tool in the Brain-Hacking Toolbox – IEEE Spectrum

A scientist wanting to hack into an animals brain used to have three different tools to choose from: electriccurrent, drugs, and light. Now theres a fourth: magnetic fields. In a paper published last week in the open-access journal eLife, scientists at the University at Buffalo used magneto-thermal genetics to manipulate brain cells in mice, enabling the researchers to control the animals behavior.

Magneto-thermal genetics has been previously shownto activate neurons in anesthetized rodent brains, but this is the first time anyone hasreported using the tool to manipulate animal behavior, says Arnd Pralle, the University at Buffalo biophysicist who led the research.

Brain hacking tools help scientists better understand the wiring of the brainthe arrangement of neural circuits and which onescontrol different movements and behaviors. These tools could someday lead to the development of artificial human eyes and ears, or treatments for paralysis,traumatic brain injury, and diseases such as Parkinsons and depression.

Over the past few years, major funding agencieshave encouraged scientists and bioengineers to focus their work on the bodys internal wiring. The U.S. National Institutes of Health (NIH) and DARPA have been doling out grants for work on both the peripheral and central nervous systems.

Engineers play a key role in the research. The bodys nervous systems communicate, after all, in a language of electrical signals. Researchers must not only map those signals, but also figure out how to interface with them, and override them when they malfunction.

Magnetic fields can do the job (following some complicated, multi-step bioengineering). In Pralles experiments, he and his team injected a virus containing a gene and some helper genetic elementsinto the brains of mice. This genetic material gets incorporated into the DNA of the mouses brain cells, or neurons. The foreign gene makes the neurons heat sensitive. Next, they injected magnetic nanoparticlesinto a specific region of the mouse brain that latch onto the neurons in that region. They then applied alternating magnetic fields, which cause the nanoparticles to heat up a couple of degrees. The rise in temperature triggers the heat-sensitive neurons to open ion channels. Positively-charged ions flow into the neuron, causing it to fire.

Pralle demonstrated proof of the concept in 2010, and others, such as Polina Anikeeva, a professor of materials science and engineering at MIT, have since improved upon it. Those studies confirmed that the technique could indeed activate neurons in the rodent brain.

In the new study, Pralle and his team show how magneto-thermal genetics can manipulate behavior in mice that are awake and freely moving. In their experiments, they activated regions of the brain that made the mice run faster around the perimeter of their cages, spin in circles, and, eerily, freeze the motion of all four paws.

Those same behaviors have been induced in rodents by activating neurons using other brain hacking tools, including optogenetics (in which neurons are genetically sensitized to respond to light), and chemogenetics (in which neurons are genetically sensitized to respond to designer drugs).

Those three toolsmagneto-thermal genetics, optogenetics, and chemogeneticsare new and purely experimental. A fourth toolelectrical stimulationhas been around for decades, with some success in treating Parkinsons, depression, memory loss, paralysis, and epilepsy in humans.

None of the tools has made a dent, relatively speaking, in the range of functions that the brain, spinal cord and peripheral nerves control. Its like owning four different musical instruments and knowing how to play onlya few rudimentary toddler songs on each of them. That untapped potential has inspired scientists to continue to test and develop the tools.

That means overcomingthe shortcomings of each tool. Electrical stimulation of deep brain regions requires, at least for now, an invasive surgical procedure to implant electrodes. That limits the number of patients willing to undergo the surgery. The method is also limited in how specifically it can target small brain regions or cell types.

Optogenetic techniques can target specific neurons, but animals in these experiments usually have to be tethered to an optical fiber or other kind of implant that delivers the light, which can affect their behavior. Study animals undergoing chemogenetic modulation can run free, but their response to the drugs is much slower than to light or electrical stimulation.

Magneto-thermal genetic toolsare non-invasive, tetherless, and induce a response within seconds of turning on the magnetic fields. But theres controversy over how the tool works.

Pralles team has shown that the magnetic nanoparticles injected into the mouse brains latch onto the membranes of the neurons, thus restricting the heating to those membranes rather than diffusing out to the surrounding liquid. This makes little sense from a physics point of view, and contradicts basic principles of heat transfer, saysMarkus Meister, a bioengineer at the California Institute of Technology in Pasadena.

Meister has also argued that previous experiments in magnetogeneticsa sister tool to magneto-thermal geneticsthat involves a different mechanismcontradict the laws of physics.He laid out his back-of-the-envelope calculations last year ina paper ineLife, whichgarnered a lot of attentionin the field of neuromodulation.

However, Pralles main claim, that he successfully used magnetic heating to control animal behavior, looks well supported, Meister says. Bottom line, the reported effects on behavior look real, but just what the mechanism is behind them remains to be understood.

Pralle says his work clearly demonstrates and measures local heating at the cell membrane, showing that it does indeed occur. Why thats happening, however, is unclear, he says.We cannot completely explain why the increase in heat stays within a few tenths or hundredths of nanometers of the neuronal membrane, Pralle says. The heat should diffuse more quickly into the [surrounding] water solution, so it shouldnt have much of a local heating effect.

Several theorists and experimentalists, including Anikeeva, have formulated and are testingmodels to explain the phenomenon. Similar effects have been seen, measured and correctly predicted for laser heating of gold nanoparticles in water, Pralle says.

Anikeeva says she sees nocontroversy in Pralles latest work. Meisters argument is based on a model that isnot applicable to nanoscale heat transport, she says.

Next, Pralle plans to develop, in collaboration with Anikeeva,a magneto-thermal genetics tool that can modulate multiple areas of the brain simultaneously, allowing the researchers to more fully control behavior, or multiple behaviors at one time. If we dream about it we can overcome the technical hurdles, Pralle says.

Go here to see the original:
Magnetothermal Genetics: A Fourth Tool in the Brain-Hacking Toolbox - IEEE Spectrum

New app studies tick disease risks – Block Island Times (press release) (subscription) (blog)

An innovative and new behavioral study is being conducted on Block Island using a free smartphone app to examine how daily activities expose people to the risks of acquiring diseases transmitted by ticks. The all-mobile research study app, called the Tick App,is available to IOS and Android smartphone users.

The app was created by Columbia Universitys tick and Lyme disease research team, led by Dr. Maria Diuk-Wasser, a professor in the Department of Ecology, Evolution and Environmental Biology (E3B). It offers the Block Island community a way to understand what activities and specific locations on the island lead to the highest risk of tick exposure. The pilot study is open, and is seeking residents and visitors on Block Island to participate by utilizing the app through September 2017. Dr. Diuk-Wasser intends to report her findings before next spring.

A summary from the research team noted that the goal of the study is to evaluate the use of ecological momentary assessments as a tool to assess risk factors for Lyme disease. This study will be conducted on Block Island, and data on human behavior will be obtained from a smartphone application using momentary assessments methodology to assess real time behavior and movement.

Were excited about the app, said Dr. Diuk-Wasser, who noted that the pilot study was hatched out of collaboration with a colleague. Dr. Diuk-Wassers team began using the app in June, and will share the results with Dr. Peter Krause, a Senior Research Scientist studying vector borne diseases at Yale University. Dr. Krause and his team will test participants at the conclusion of the study at the end of September.

Dr. Diuk-Wasser said subjects will participate using the app for about three weeks during the study. She said the app tracks the participants range of movement daily providing mapping information about dangerous areas on the island. She is hopeful that her research draws a large field of participants.

Dr. Diuk-Wasser has been working on Block Island since 2010, investigating links between the islands environment, animal populations, and human cases of Lyme disease. Other members of her research team are Pilar Fernandez, an Earth Institute post-doctorate fellow, and Pallavi Kache, who will be starting her PhD program at E3B in the fall.

Fernandez, who has been leading the teams communication efforts, said the app provides a way to use new tools and resources to conduct our research.She noted that users can participate using either a username, or their own name if they choose. Were the only ones who will be accessing the data from the study, she said.

According to a press release, The Tick App uses a combination of pop-up survey questions and geolocation technology to collect data. With these functions, Dr. Diuk-Wassers research team will be able to uncover how peoples day-to-day activities and movement around the island play a role in their risk for tick bites and tick-borne diseases. This information can help develop disease-control programs that take the lifestyle of the Block Island community into consideration and help develop educational programs to reduce disease risk.

The Tick App asks participants to:

Answer two multiple-choice questions sent at random times each day about their current activity

Answer two multiple-choice questions at the end of each day about all the activities they did that day

Answer one fill-in-the-blank questionnaire at the end of each day about how many ticks they found on themselves and their pet (if applicable)

Turn on location services so that the participants movement around the island can be detected

The summary states that the aim of the research is to recruit 100 Block Island residents and 100 visitors who have a personal smartphone. Vulnerable populations, such as pregnant women, the elderly, or children, will be excluded. The study will produce highly precise behavioral data about tick exposure which will lead to deepen our understanding on what intervention strategies might be most needed and most effective, pertaining to the fight against tick-borne disease.

The Block Island Times reported on Dr. Diuk-Wassers five-year research study that she presented at the Island Free Library on July 11, 2016. During her presentation she explained the pivotal role that deer and mice play in the spread of tick-borne diseases on Block Island.

To learn more about the app or to schedule an interview, contact: Maria Diuk-Wasser, PhD, Associate Professor, Department of Ecology, Evolution, and Environmental Biology at Columbia University. Phone: 212-854-3355 E-mail: bitickapp@gmail.com, Website: http://www.columbia.edu/~mad2256, Study Website: https://thetickapp.org/ and Twitter: @diukwasserlab. Dr. Diuk-Wasser said she is seeking additional funding to further the evolution of the app and her studies, which she hopes to continue into the near future.

Read more from the original source:
New app studies tick disease risks - Block Island Times (press release) (subscription) (blog)

The Killings Of Black Men Are More Likely To Be Labelled ‘Justifiable’ – GOOD Magazine

When George Zimmerman went on trial four years ago for the shooting of 17-year-old Trayvon Martin, the Sanford (Florida) Police Department senta request to the states attorney asking whether his death would be determined a justifiable homicide. Under Floridas stand your ground laws, such a designation would allow Zimmerman to claim his killing of Martin occurred in self-defense and he did so, successfully.

By the time the jury delivered a not guilty verdict for Zimmerman in 2013, self-defense had become an increasingly common rationalization for homicide cases in the U.S.as stand your ground laws proliferated state-by-state. In Florida,therateof justifiable homiciderose200%from 2005, when stand your ground went into effect, to 2013.

A new report by the Marshall Project published this month,which examines FBI data about 400,000 civilian homicides,finds that cases are far more likely to be determined justifiable homicides when the killer is white and the victim is black. In fact, while justifiable homicides only constituted 2% of all cases, that percentage swelled to 17%when the cases involved a white civilian killing a black civilian. According to the authors of the Marshall Project report:

The vast majority of killings of whites are committed by other whites, contrary to some folk wisdom, and the overwhelming majority of killings of blacks is by other blacks. But killings of black males by white people are labeled justifiable more than eight times as often as others. This racial disparity has persisted for decades and is hard to explain based solely on the circumstances reported by the police data.

The phrase justifiable homicide is one of those oddities of a justice system that seeks to make room for human fallibility in legal classification and language for example, homicides committed by domestic violence victims against their abusers. But these adjustments for the failures of human judgment end up accommodating prejudices and biases that disproportionately benefit nonblack defendants and victimize black victims. It's not just white-on-black self-defense claims, says Jody David Armour, a professor of law at the University of Southern California. It's any self-defense claims that include a black victim, whether the shooter is white, black, Latino, or Asian.

Jody David Armour. Photo courtesy of the University of Southern California.

Armour is the author of Negrophobia and Reasonable Racism: The Hidden Costs of Being Black in America, a 1997 book that examined how unconscious racism against black people manifests systemicallyin institutions like the justice system.

The key legal test for determining whether a homicide was justifiable is something called the reasonable person standard, says Armour in cases involving civilians or a police officer. The test asks one simple question: Would a reasonable person in this situation detect an imminent threat by the victim?

The way the law defines 'reasonable' is not 'rational,' says Armour. Reasonable does not mean right. All reasonable means is 'typical.' 'Ordinary.' You're a reasonable person if you're an ordinary person, if you're the average person.

A persons reasonableness insulates them from accountability when their mistakes are determined to fall within the spectrum of typicalhuman behavior and inadequacy. The reasonable person test says you don't condemn somebody who's just expressed ordinary human frailty in whatever they've done, says Armour. But human failure is not always natural or predetermined its often influenced by the social environments in which we are raised.

The problem with the typical is reasonable approach, which is the one we use in a court, is that it would let off the hook a lot of, for example, Germans in Nazi Germany in 1939 or 1940, adds Armour. If they could say, Hey, I was anti-Semitic but it was typical to be anti-Semitic. You can't blame me for being anti-Semitic if most people around me were.

Though Charlottesville made it clear that anti-Semitism is on the rise in America, racism is undeniably a foundational characteristic of contemporary American society, embedded in the body politic. So it stands to be argued that a reasonable person in the United States is likely a racist one, too.

We know that at an unconscious level, ordinary people harbor negative stereotypes about blacks, says Armour. And among those stereotypes that ordinary people harbor about blacks are that blacks are more violent and crime-prone. That stereotype can operate unconsciously, automatically.

A 1976 study by University of California, Berkeley, professor Birt Duncan exemplifies the ways in which these unconscious beliefs function in real life. Duncan made his subjects of varied races view and evaluate a taped interaction between two people having a discussion about another colleagues job placement. The conversation becomes heated, and one of them gets up to leave, ambiguously bumping the other person on their way out.

When someone black initiated that ambiguous bump, the subjects were much more likely to interpret the bump as hostile or violent. When someone white initiated the same bump, the subject was much more likely to interpret it as merely horseplay or dramatized, says Armour. This pattern of judgment was the same whether the subject was black or white. These findings reveal how ordinary Americans have been socialized to read aggression into the behaviors and movements of black people behaviors that would otherwise be read as nonthreatening when performed by a white people.

If 'reasonable' means 'typical,' then the question becomes, 'Does a typical person in America consider race, consider blackness, when they're assessing the dangerousness of an ambiguous or suspicious person? asks Armour. And the tragic truth is, study after study shows and we know it if we just consult our own intuition that ordinary people in America, ordinary people do consider race when they're assessing someone's dangerousness.

This is why, for example, black men frequently observe white women clutching their purses a little tighter when they walk past them on the street. Its a psychological tic that reporter Frederick H. Lowe explored in an article for the Chicago Reader called the The Clutch of Fear, calling it a form of racist signaling. In it, he interviewed psychiatrist Carl Bell, who said:"It's a nonverbal kinetic that wears at a black man's self-esteem. A white woman sees a black man and she instantly stereotypes him as someone who plans to rape and rob her.

There is a mental tax for these kinds of interactions, levied mostly against black men. This type of projection depletes a black man's energy because he constantly thinks about it, said Bell. It limits his mobility. And it impinges on his life, because he's constantly kept off guard, preventing him from focusing on other issues."

And in places where guns are easily accessible, its not just a black persons energy or mental health that is threatened its their very life, as demonstrated in the case of Trayvon Martin. Zimmerman, an ordinary person, harboring many of the same prejudices that the white women in The Clutch of Fear cling to, determined that Martins behaviors were hostileand that Martin, a 17-year-old boy, posed an imminent threat to his life. Zimmermans possession of a gun allowed him to act on that split-second judgment with violence, taking Martins life.

But in the eyes of the law, Zimmermans killing was consideredjustifiable because his perceptions matched those of an ordinary jury. This legal applicationempties the word of its meaning what becomes clear is that in at least one case of justifiable homicide, justicewas not dispensed.

Share image and top image byKena Betancur/Getty Images.

See the article here:
The Killings Of Black Men Are More Likely To Be Labelled 'Justifiable' - GOOD Magazine

Royan to hold intl. twin congress on reproduction, stem cells – Mehr News Agency – English Version

Royan International Twin Congress on Reproductive Biomedicine and Stem Cells Biology & Technology is a joint of two separate congresses with different themes held by Royan Research Institute Reproductive Biomedicine and Stem Cells Research Center.

The two joint events include the 18thCongress on Reproductive Biomedicine and 13thCongress on Stem Cell Biology and Technology scheduled for August 30- September 1, 2017.

Royan International Research Award winners, including five foreign and five Iranian researchers, will present their researchers on Reproductive Biomedicine and Stem Cell Biology & Technology during the Congress time.Each winner will be rewarded with a certificate, the symbol of Royan Award and a cash prize.

Main topics of the 18th congress on Reproductive Biomedicine include Low Fertilization Rate, Repeated Pregnancy Loss, Psychological Issues in Infertility, and Animal Biotechnology among many other related topics. The main topics of the 13th Congress on Stem Cell Biology include Cell Technology, Regenerative Medicine, Tissue Engineeringand Cancer Stem Cellsamong others.

This years edition of the congress received 194 papers, 91 of which penned by foreign researchers from US, UK, China, Australia, India, Italy, Lebanon, the Netherlands, Canada, France, Egypt, Belgium, Malaysia, Turkey and Iraq.

MS/4069209

More:
Royan to hold intl. twin congress on reproduction, stem cells - Mehr News Agency - English Version

This Common Ingredient in Antiseptic Soap Is Messing With Your Cell Biology – ScienceAlert

A common class of antiseptic found in everything from mouthwash to spermicides has been found to impair the workings of our cells' mitochondria the parts of the cell that convert glucose into other forms of chemical energy.

Concerns over the class of antimicrobial agents called quaternary ammonium compound has been so great, the US Food and Drug Administration (FDA) has already banned one of the chemicals from certain products and asked for more information on another.

Researchers from the University of California, Davis, tested two common forms of quaternary ammonium salts called cetylpyridinium chloride (CPC) and benzalkonium chloride (BAK) on human tissues under laboratory conditions.

This class of antimicrobial commonly shortened to QUATS is literally in just about everything. Soaps, body washes, lozenges, deodorants, toothpastes ... nearly anything you can think of as some sort of personal care product uses them to keep bacteria at bay.

Many QUATS have a rather nasty effect on microbes, ripping into their membranes in relatively low concentrations thanks to their fat-loving chemistry.

Because they aren't chemically altered by this action, the compounds retain their biocidal characteristics even after they've washed into the environment.

This has raised alarms in the past, where QUATS were found to cause reproductive problems in mice.

In 2016, the FDA ruled that the antiseptic compounds CPC and BAK were no longer recognised as safe to use in certain products, and made a call for more evidence to determine BAK's risks.

For their study, the researchers tested a collection of 1,600 FDA-approved and clinically approved antiseptics, additives, and drugs on two kinds of human cell line under in-vitro conditions.

In this case, those that contained QUATS were found to interfere with the workings of mitochondria, derailing an important transfer of electrons and inhibiting the organelle's ability to produce energy-carrying molecules called adenosine triphosphate (ATP).

Those that contained CPC were the most potent of the lot.

Just how this translates from a Petri dish to the real world of human and other animal bodies is yet to be fully established, but it's not looking positive, especially when complicated by other forms of medication.

"This raises concern because exposure to other mitochondrial-inhibiting drugs, such as rotenone and MPTP, is associated with increased risk for Parkinson's disease," says researcher Gino Cortopassi from UC Davis.

Not only do these antimicrobial agents lower the mitochondria's ability to pump out ATP, the researchers found that at certain concentrations they also interfered with the cell's response to an important reproductive hormone.

"Disinfectants that we are putting on and in our bodies, and using in our environment, have been shown to inhibit mitochondrial energy production and the cellular estrogen response," says Cortopassi.

In 2016, the FDA banned soaps and detergents that contained chemicals from a list of ingredients that included popular antimicrobials such as triclosan and triclocarbon, claiming there was greater potential for harm than benefits.

QUATS were being considered by some companies as possible safe replacements for these agents.

"This paper adds to the growing number of studies which find that QUATS may not be as safe as previously believed," says Terry Hrubec from theE. Via College of Osteopathic Medicine, who wasn't a researcher in this study.

The chemical category is a relatively large one, and not all QUATS compounds seem to behave in the same ways.

With the chemicals so prevalent that nearly all of us come into contact with them on a daily basis, more research is needed as soon as possible to tease out which could potentially be safe.

This research was published in Environmental Health Perspectives.

Original post:
This Common Ingredient in Antiseptic Soap Is Messing With Your Cell Biology - ScienceAlert

A new clue to hair loss: A misbehaving enzyme in follicle stem cells – STAT

T

he roots of hair loss run deep: Its linked to hormonal balance, immune response, stem cell signaling, and now, according to new research from University of California, Los Angeles metabolism.

The study, published inNature Cell Biology, finds that the metabolism in the stem cells embedded in hair follicles is different from surrounding cells. When they tinkered with that metabolic pathway in mice, they could either halt hair growth or make it proliferate. The UCLA researchers are now testing out a duo of drugs to try and prompt that hair to grow.

This is a STAT Plus article and is only available to STAT Plus subscribers.To read the full story, subscribe to STAT Plus or log in to your account.Good news: your first 30 days are on us.

Biotech Correspondent

Meghana covers biotech and writes The Readout newsletter.

See the original post here:
A new clue to hair loss: A misbehaving enzyme in follicle stem cells - STAT

Lockdown genes to reduce IVF failure rates – Medical Xpress

A*STAR scientists in the Developmental Epigenetics and Disease group. Credit: A*STAR Institute of Molecular and Cell Biology

Embryos kickstart a vibrant genetic program to thrive, but if the wrong genes are active the cells can self-destruct. A*STAR scientists have discovered one of the genes that needs to be tightly locked down for an embryo to develop: a finding that could improve IVF success rates.

Human egg and sperm cells have their genes trained on a single purpose to fertilize. Once their mission is complete, the developing embryo begins the complicated genetic program that turns a single cell into a healthy fetus.

This program is possible thanks in part to epigenetic changes to the DNA, such as the removal of methyl group 'locks' by enzymes, which allows many more genes to be read.

Some specialized genes however need to be locked down during development, as their genetic messages cause problems for the embryo.

"Everything that goes wrong in embryos has the potential to cause infertility or early pregnancy abortions," explains Daniel Messerschmidt from the A*STAR Institute of Molecular and Cell Biology. "We are keen to discover the genomic locations which impact on that development."

Messerschmidt's team previously discovered that a protein called Trim28 locks methyl groups to certain regions in the genome. Now, the researchers looked for the targets of Trim28 to find what genes lies within these regions.

The scientists sequenced the RNA of more than 30 embryos lacking Trim28 and discovered that a gene called Rbmy1a1 was unusually active.

"It's an interesting gene which is not expressed anywhere in the body during development except for spermatogonia in the testes it has no place to be expressed in the embryo," says Messerschmidt. He proposes that the enzyme encoded by Rbmy1a1 produces mRNA transcripts which are harmful to the developing embryo.

Messerschmidt's team is now looking for more of these 'special attention' genes. If the activity of detrimental genes such as Rbmy1a1 can be detected before an embryo is implanted, then it could improve rates of IVF success, says Messerschmidt.

"We want to find out whether we can do epigenetic diagnostics in the same way as when we screen for a suspected genetic disease," he says. "Ultimately, having an overall understanding of these processes will give us a basis for what to look at."

Messerschmidt adds that an epigenetic diagnostic tool for embryos may allow doctors to compare IVF methods which differ between labs. "If we can compare different methods, perhaps we can point doctors to techniques that improve efficiency," he says.

Explore further: Single-cell analysis shows how embryonic cells maintain proper patterns of gene regulation

More information: Abhishek Sampath Kumar et al. Loss of maternalTrim28causes male-predominant early embryonic lethality, Genes & Development (2017). DOI: 10.1101/gad.291195.116

More:
Lockdown genes to reduce IVF failure rates - Medical Xpress